Published in Ann Intern Med on December 19, 2000
Nurses' Health Study (Cardiovascular Component) | NCT00005152
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87
The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause (2012) 4.04
Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring. Hypertension (2007) 2.31
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Menopause (2011) 2.06
Why primate models matter. Am J Primatol (2014) 2.05
Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol (2009) 2.01
The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev (2013) 1.93
Observation plans in longitudinal studies with time-varying treatments. Stat Methods Med Res (2008) 1.89
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause (2008) 1.74
Six persistent research misconceptions. J Gen Intern Med (2014) 1.61
Menopausal hormone therapy is associated with having high blood pressure in postmenopausal women: observational cohort study. PLoS One (2012) 1.56
Impact of lifelong exercise "dose" on left ventricular compliance and distensibility. J Am Coll Cardiol (2014) 1.56
Hormone replacement therapy: a time for pause. CMAJ (2002) 1.52
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain (2012) 1.40
Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol (2009) 1.39
Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens (2011) 1.24
Observational versus experimental studies: what's the evidence for a hierarchy? NeuroRx (2004) 1.23
Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch Intern Med (2008) 1.21
Limitations of observational evidence: implications for evidence-based dietary recommendations. Adv Nutr (2014) 1.19
Stroke risk in women: the role of menopause and hormone therapy. Lancet Neurol (2012) 1.10
Estrogen Deficiency and the Origin of Obesity during Menopause. Biomed Res Int (2014) 1.08
Stroke in women: disparities and outcomes. Curr Cardiol Rep (2010) 1.07
The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial. BMC Womens Health (2007) 1.07
Sex steroidal hormones and respiratory control. Respir Physiol Neurobiol (2008) 1.03
Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med (2011) 1.02
Depressive behavior and coronary artery atherogenesis in adult female cynomolgus monkeys. Psychosom Med (2008) 1.02
Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels. Curr Med Chem (2009) 1.01
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Womens Health (Larchmt) (2009) 1.00
Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm Behav (2012) 0.99
Circulating AIM as an indicator of liver damage and hepatocellular carcinoma in humans. PLoS One (2014) 0.97
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective. Curr Med Chem (2014) 0.96
A "window of opportunity:" the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent. Brain Res (2010) 0.96
A case-control study on the effect of hormone replacement therapy on ischaemic heart disease. Br J Gen Pract (2003) 0.93
Postmenopausal hormone therapy: risks and benefits. Nat Rev Endocrinol (2013) 0.93
Cardiovascular Disease in Women: Clinical Perspectives. Circ Res (2016) 0.92
Postmenopausal hormone therapy and cardiovascular disease in perspective. Clin Obstet Gynecol (2008) 0.92
The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective. Climacteric (2012) 0.91
Results of observational studies: analysis of findings from the Nurses' Health Study. PLoS One (2014) 0.91
Dose-dependent cardiac effect of oestrogen replacement in mice post-myocardial infarction. Exp Physiol (2008) 0.90
Influence of maternal dysmetabolic conditions during pregnancy on cardiovascular disease. J Cardiovasc Transl Res (2009) 0.90
Gender specific patterns of age-related decline in aortic stiffness: a cardiovascular magnetic resonance study including normal ranges. J Cardiovasc Magn Reson (2015) 0.88
Premature menopause. Ann Med Health Sci Res (2013) 0.88
Assessing observational studies of medical treatments. Emerg Themes Epidemiol (2005) 0.88
Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women. J Clin Endocrinol Metab (2009) 0.88
Lessons from the Women's Health Initiative: primary prevention and gender health. CMAJ (2002) 0.88
Positive pressure therapy: a perspective on evidence-based outcomes and methods of application. Proc Am Thorac Soc (2008) 0.88
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene. Clin Interv Aging (2010) 0.87
Hormones to prevent coronary disease in women: when are observational studies adequate evidence? Ann Intern Med (2000) 0.87
Estrogen and neuroprotection: from clinical observations to molecular mechanisms. Dialogues Clin Neurosci (2002) 0.86
Vascular effects of estrogenic menopausal hormone therapy. Rev Recent Clin Trials (2012) 0.85
Perspectives on hormone replacement therapy: the Women's Health Initiative and new observational studies sampling the overall population. Fertil Steril (2008) 0.85
Estrogen effects on vascular inflammation are age dependent: role of estrogen receptors. Arterioscler Thromb Vasc Biol (2014) 0.85
Estradiol attenuates neuroprotective benefits of isoflurane preconditioning in ischemic mouse brain. J Cereb Blood Flow Metab (2008) 0.85
Vascular Aging in Women: is Estrogen the Fountain of Youth? Front Physiol (2012) 0.85
Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study. BMJ (2003) 0.84
Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy. Circulation (2012) 0.84
Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril (2013) 0.83
Dose-dependent toxic effects of high-dose estrogen on renal and cardiac injury in surgically postmenopausal mice. Life Sci (2010) 0.83
Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes. Menopause (2011) 0.83
Endothelial function in women of the Kronos Early Estrogen Prevention Study. Climacteric (2015) 0.82
Age-related differences in cardiac ischemia-reperfusion injury: effects of estrogen deficiency. Pflugers Arch (2013) 0.81
Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause. Eur J Prev Cardiol (2015) 0.81
Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease. Cardiovasc Hematol Agents Med Chem (2010) 0.80
Increased cardiovascular and renal risk is associated with low nephron endowment in aged females: an ovine model of fetal unilateral nephrectomy. PLoS One (2012) 0.79
Frequency of symptoms and health seeking behaviours of menopausal women in an out-patient clinic in Port Harcourt, Nigeria. Glob J Health Sci (2013) 0.79
Hormone Replacement Therapy for Primary and Secondary Prevention of Heart Disease. Curr Treat Options Cardiovasc Med (2003) 0.79
Should symptomatic menopausal women be offered hormone therapy? MedGenMed (2006) 0.78
Differential effects of medroxyprogesterone acetate on thrombosis and atherosclerosis in mice. Br J Pharmacol (2009) 0.78
Lasofoxifene: Evidence of its therapeutic value in osteoporosis. Core Evid (2010) 0.78
Determinants of hormone therapy discontinuation among female veterans nationally. Mil Med (2008) 0.78
The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset? Metabolism (2016) 0.77
Hormone therapy and stroke: is it all about timing? Curr Treat Options Cardiovasc Med (2009) 0.77
Alcohol consumption negates estrogen-mediated myocardial repair in ovariectomized mice by inhibiting endothelial progenitor cell mobilization and function. J Biol Chem (2013) 0.77
The associations of hormone replacement therapy and preventive practices in minority women. J Natl Med Assoc (2005) 0.76
Critique of the International Agency for Research on Cancer's meta-analyses of the association of sunbed use with risk of cutaneous malignant melanoma. Dermatoendocrinol (2009) 0.76
Heart disease and hormones. Tex Heart Inst J (2011) 0.76
Attitude to the Menopause and Sex amongst Middle-Aged Women in a Family Medicine Clinic in Ibadan, Nigeria. Obstet Gynecol Int (2016) 0.75
Estrogen-induced improvement in coronary flow responses during atrial pacing in relation to endothelin-1 levels in postmenopausal women without coronary disease. Vasc Health Risk Manag (2008) 0.75
Influence of body weight on the biochemical indicators in menopause. Mater Sociomed (2014) 0.75
Sex hormone therapy and progression of cardiovascular disease in menopausal women. Clin Sci (Lond) (2016) 0.75
Menopause and hormone replacement: Part 1. Evaluation and treatment. West J Med (2001) 0.75
Overweight and effect of hormone replacement therapy on lipid profiles in postmenopausal women. Korean J Intern Med (2005) 0.75
Hormone replacement therapy and risk of atrial fibrillation in Taiwanese menopause women: A nationwide cohort study. Sci Rep (2016) 0.75
The effect of 17β-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu. J Mol Endocrinol (2011) 0.75
Revisiting estrogen: efficacy and safety for postmenopausal bone health. J Osteoporos (2010) 0.75
Postmenopausal hormone therapy and cardiovascular disease. Ann Intern Med (2001) 0.75
High-Dose Estradiol-Replacement Therapy Enhances the Renal Vascular Response to Angiotensin II via an AT2-Receptor Dependent Mechanism. Adv Pharmacol Sci (2015) 0.75
Soy consumption during menopause. Facts Views Vis Obgyn (2012) 0.75
Postmenopausal hormone therapy and cardiovascular disease. Ann Intern Med (2001) 0.75
Long-Term Hormone Replacement Therapy Is Associated with Low Coronary Artery Calcium Levels in a Cohort of Older Women: The Age, Gene/Environment Susceptibility-Reykjavik Study. J Am Geriatr Soc (2016) 0.75
Association of Female Reproductive Factors with Hypertension, Diabetes and LQTc in Chinese Women. Sci Rep (2017) 0.75
Estrogen and Cardiovascular Disease: Is Timing Everything? Am J Med Sci (2015) 0.75
Menopausal Hormone Therapy, Age, and Chronic Diseases: Perspectives on Statistical Trends. Chem Res Toxicol (2016) 0.75
Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen. Stroke (2016) 0.75
High Maternal Serum Estradiol Levels Induce Dyslipidemia in Human Newborns via a Hepatic HMGCR Estrogen Response Element. Sci Rep (2015) 0.75
Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease. Curr Hypertens Rev (2009) 0.75
Estrogenic vascular effects are diminished by chronological aging. Sci Rep (2017) 0.75
An association between air pollution and mortality in six U.S. cities. N Engl J Med (1993) 38.84
Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17
Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85
Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med (1995) 15.80
Observations on recent increase in mortality from asthma. Br Med J (1968) 14.82
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
Body weight and mortality among women. N Engl J Med (1995) 11.04
Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98
Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84
Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11
Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90
Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90
Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59
Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28
Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med (2000) 9.05
Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med (1990) 8.98
Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66
Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64
Annual deaths attributable to obesity in the United States. JAMA (1999) 8.62
A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
Test of the National Death Index. Am J Epidemiol (1984) 8.46
Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43
Misinterpretation and misuse of the kappa statistic. Am J Epidemiol (1987) 8.29
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 8.17
The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health (1997) 8.00
Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet (1991) 7.87
Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62
A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol (1990) 7.24
Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11
Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09
Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med (2001) 7.07
Guidelines for healthy weight. N Engl J Med (1999) 7.03
Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr (1999) 7.02
Plasma organochlorine levels and the risk of breast cancer. N Engl J Med (1997) 7.02
Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92